These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 4642650)
21. [Substitution therapy with factor 8 and factor IX preparations]. Landbeck G Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465 [No Abstract] [Full Text] [Related]
22. New alternatives and strategies in the treatment of inhibitors. Hoyer LW Prog Clin Biol Res; 1984; 150():367-72. PubMed ID: 6431440 [TBL] [Abstract][Full Text] [Related]
23. [Treatment of patients suffering from hemophilia with stenosing hemorrhages into the region of the upper respiratory tract]. Barkagan ZS Vestn Otorinolaringol; 1971; 33(5):93-6. PubMed ID: 5152574 [No Abstract] [Full Text] [Related]
24. The hemophiliac's demand on blood resources: the magnitude of the problem. Stengle JM Ann N Y Acad Sci; 1975 Jan; 240():155-61. PubMed ID: 1053861 [No Abstract] [Full Text] [Related]
25. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia. McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730 [TBL] [Abstract][Full Text] [Related]
26. The preparation of an artificial reagent for the one-stage factor VIII assay. Nyman D Thromb Diath Haemorrh; 1970 May; 23(2):206-12. PubMed ID: 5426208 [No Abstract] [Full Text] [Related]
29. Procoagulant factors and the risk of myocardial infarction in young women. Tanis B; Algra A; van der Graaf Y; Helmerhorst F; Rosendaal F Eur J Haematol; 2006 Jul; 77(1):67-73. PubMed ID: 16608503 [TBL] [Abstract][Full Text] [Related]
30. [Inhibitor hemophilia in oral surgery]. Schulz S Zahn Mund Kieferheilkd Zentralbl; 1984; 72(8):824-8. PubMed ID: 6240865 [No Abstract] [Full Text] [Related]
31. Prophylactic transfusion for hypertrophic synovitis in children with hemophilia. Greene WB; McMillan CW; Warren MW Clin Orthop Relat Res; 1997 Oct; (343):19-24. PubMed ID: 9345200 [TBL] [Abstract][Full Text] [Related]
32. Physiologic considerations in the management of hemophilia. Briggs DK Pathobiol Annu; 1971; 1():205-14. PubMed ID: 4950380 [No Abstract] [Full Text] [Related]
33. Characterization of procoagulants produced in cell cultures by tests of coagulation. Zacharski LR; McIntyre OR Thromb Diath Haemorrh; 1971 Dec; 26(3):493-502. PubMed ID: 5144962 [No Abstract] [Full Text] [Related]
34. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980-1982). Christensen RL; Triplett DA Am J Clin Pathol; 1983 Oct; 80(4 Suppl):633-42. PubMed ID: 6414289 [TBL] [Abstract][Full Text] [Related]
35. A comparison between a serum fraction and FEIBA fraction in haemophilia. Hutton RA; Dormandy K; Nour-Eldin F New Istanbul Contrib Clin Sci; 1980; 13(1):9-22. PubMed ID: 6774316 [No Abstract] [Full Text] [Related]
37. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma. Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562 [TBL] [Abstract][Full Text] [Related]
38. Orthopedic and medical treatment of patients with hemophilia. Spivack AR Arch Intern Med; 1983 Jul; 143(7):1431-3. PubMed ID: 6409022 [No Abstract] [Full Text] [Related]
39. Blood coagulation values of sheep. Gajewski J; Povar ML Am J Vet Res; 1971 Mar; 32(3):405-9. PubMed ID: 5547008 [No Abstract] [Full Text] [Related]